** Shares of drug distributor McKesson MCK.N rise 4.5% to $721
** MCK late on Thursday forecast fiscal year 2026 profit largely above estimates
** Company said it is planning to spin off its medical-surgical solutions unit into an independent company to focus on its core drug distribution business
** Expects per-share profit in the range of $36.75 to $37.55 for 2026, compared with analysts' average estimate of $36.76 -data compiled by LSEG
** Posted Q4 earnings of $10.12 per share vs estimate of $9.82 per share
** Including session's moves, stock up 21.1% YTD
(Reporting by Siddhi Mahatole)
((siddhi.mahatole@thomsonreuters.com))
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。